Matt Birrenkott is currently the Director of Clinical Science at Immunome, Inc., a position held since 2024. Previously, they served as a Principal Clinical Scientist at Seagen from 2022 to 2023 and as a Clinical Science Postdoctoral Fellow at Genentech from 2018 to 2020. Matt's experience also includes roles as a Clinical Lab Assistant at Intermountain Healthcare from 2007 to 2014 and as a Pharmacist Intern at Huntsman Cancer Institute from 2014 to 2018. Additionally, they were a Pharmacy Student Researcher at the University of Utah College of Pharmacy from 2015 to 2016, showcasing a strong background in clinical science and research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices